Universitätsklinikum Würzburg

Venetoclax-Based Salvage Therapy Improves Outcome in Relapsed/Refractory AML Patients Eligible for Intensive Treatment: A Propensity Score Matching Analysis (2022) Unglaub JM, Schlenk RF, Hanoun M, Reinhardt HC, Middeke JM, Schaefer-Eckart K, Steffen B, et al. Conference contribution Tandem Duplications of the UBTF gene in Adult AML: A Rare but Recurrent Alteration Associated with Myelodysplasia and Poor Outcome (2022) Georgi JA, Stasik S, Zukunft S, Hartwig M, Roellig C, Oelschlaegel U, Krug U, et al. Conference contribution Harnessing the Expression of TNFR2 on Tregs to Prevent Agvhd (2022) Vargas JG, Kanzler C, Scheller L, Kreckel J, Shaikh H, Lang I, Medler J, et al. Conference contribution S2k Guideline for the diagnosis and treatment of mucous membrane pemphigoid (2022) Hofmann SC, Gunther C, Bockle BC, Didona D, Ehrchen J, Gaskins M, Geerling G, et al. Journal article Serious Adverse Drug Reactions to Antipsychotics in Minors with Multiple Disabilities: Preventability and Potential Cost Savings by Therapeutic Drug Monitoring (2022) Fekete S, Guentzel T, Egberts K, Geissler J, Neubert A, Gerlach M, Romanos M, Taurines R Journal article Patient Preferences in Hidradenitis Suppurativa (APProach-HS): a discrete choice experiment (2022) Faverio K, Peitsch WK, Görig T, Schneider-Burrus S, Benzel F, Goebeler M, Schummer P, et al. Journal article Imaging of C-X-C Motif Chemokine Receptor 4 Expression in 690 Patients with Solid or Hematologic Neoplasms Using 68Ga-Pentixafor PET (2022) Buck AK, Haug A, Dreher N, Lambertini A, Higuchi T, Lapa C, Weich A, et al. Journal article Early CRP kinetics predict long-term treatment success and favorable outcomes of anti-PD-(L)1 immune checkpoint blockade in metastatic urothelial carcinoma (2022) Klümper N, Sikic D, Saal J, Buettner T, Jarczyk J, Zeuschner P, Weinke M, et al. Conference contribution Multicentric validation of a comprehensive geriatric assessment to predict functional outcome and mortality following urooncological operations (2022) Fiebig C, Kahlmeyer A, Bannert H, Taubert H, Wach S, Koneval L, Graf S, et al. Conference contribution Response to First-Line Treatment with Immune-Checkpoint Inhibitors in Patients with Advanced Cutaneous Squamous Cell Carcinoma: A Multicenter, Retrospective Analysis from the German ADOReg Registry (2022) Haist M, Stege H, Lang BM, Tsochataridou A, Salzmann M, Mohr P, Schadendorf D, et al. Journal article